Homepage

Sandoz HACk - Healthcare Access Challenge

Three winners of 2019 Sandoz Healthcare Access Challenge (HACk) are announced at SXSW
Read More
our-mission-and-purpose

Our Mission and Purpose

We are a global leader in generic and biosimilar pharmaceuticals, committed to driving access to medicine
Read More

Explore Novartis

About Us
Who We Are
Our Work
What We Do
About Us
Corporate Responsibility
Careers
Job Search

Recent Updates

Equal access to medicine – A day in the life of a healthcare professional in Brazil
Featured / Dec 04

Equal access to medicine – A day in the life of a healthcare professional in Brazil (6 min read)

As a cardiologist in Brazil, Dr. Fabiana Marcondes-Braga serves as a physician and teacher in both the private ...

Learn More
View All
Media Release / Jun 14

New Sandoz biosimilar adalimumab data confirms switching from reference biologic has no impact on safety or efficacy

Read More
Media Release / May 15

Sandoz announces plan to improve competitiveness and realign the organization, to drive ongoing Transformation and support future growth

Read More
Media Release / May 09

Sandoz demonstrates strategic focus on China, with first-of-a-kind generic approval under Quality Consistency Evaluation system

Read More
Media Release / Apr 30

Sandoz enters agreement for proposed trastuzumab biosimilar, currently in Phase III development, to treat selected HER2-positive cancer tumors

Read More
View All
Over the next decade, US taxpayers and patients could save billions if policies incentivizing #biosimilar adoption… https://t.co/QOoNGUlufQ 1 hour 1 min ago

Our Work

At Sandoz, we discover new ways to improve and extend people’s lives. We pioneer novel approaches to help people around the world access high-quality medicine.

Learn More